BETA-PENTAFLUOROPHENYL-[(2R)-N-(TERT.-BUTOXYCARBONYL)-ALPHA-METHYLASPATYL]-BETA-(2S)-PHENYLALANYL-BETA-ALANYL-[ALPHA-METHYL-(2R)-GLUTAMYL]-GAMMA-S
Compound with spectra: 1 NMR
![BETA-PENTAFLUOROPHENYL-[(2R)-N-(TERT.-BUTOXYCARBONYL)-ALPHA-METHYLASPATYL]-BETA-(2S)-PHENYLALANYL-BETA-ALANYL-[ALPHA-METHYL-(2R)-GLUTAMYL]-GAMMA-S](/api/compound/KPtXejgPmqh.png?ph=true&h=300&w=458 "BETA-PENTAFLUOROPHENYL-[(2R)-N-(TERT.-BUTOXYCARBONYL)-ALPHA-METHYLASPATYL]-BETA-(2S)-PHENYLALANYL-BETA-ALANYL-[ALPHA-METHYL-(2R)-GLUTAMYL]-GAMMA-S")
| SpectraBase Compound ID | KPtXejgPmqh |
|---|---|
| InChI | InChI=1S/C37H44F5N5O12/c1-37(2,3)59-36(55)46-22(35(54)57-6)17-24(49)45-21(16-19-10-8-7-9-11-19)33(52)43-15-14-23(48)44-20(34(53)56-5)12-13-25(50)47(4)18-26(51)58-32-30(41)28(39)27(38)29(40)31(32)42/h7-11,20-22H,12-18H2,1-6H3,(H,43,52)(H,44,48)(H,45,49)(H,46,55)/t20-,21-,22+/m1/s1 |
| InChIKey | QDXPYXRMJIZXQS-VSKRKVRLSA-N |
| Mol Weight | 845.8 g/mol |
| Molecular Formula | C37H44F5N5O12 |
| Exact Mass | 845.290663 g/mol |
| Enantiomer InChIKey | QDXPYXRMJIZXQS-FDFHNCONSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
N-(9H-Fluorene-9-ylmethoxycarbonyl)-L-leucine pentafluorophenyl ester
N-(Fluoren-9-ylmethoxycarbonyl)-threonine pentafluorophenyl ester
N-(9H-Fluorene-9-ylmethoxycarbonyl)-L-valine pentafluorophenyl ester
ARGIFIN;CYCLO-(N-(OMEGA)-(N-METHYLCARBAMOYL)-L-ARGINYL-N-METHYL-L-PHENYLALANYL-BETA-L-ASPARTYL-D-ALANYL
BOC-GLU-(O-TERT.-BUTYL)-TYR-[SO2C6H4(4-COOH)]-LEU-OBZL
NORKA
BACILLOPEPTIN-A
BACILOPEPTIN-C
BACILOPEPTIN-B
OSCILLAMIDE-B
| Title | Journal or Book | Year |
|---|---|---|
| Design and preparation of serine–threonine protein phosphatase inhibitors based upon the nodularin and microcystin toxin structures: Part 1. Evaluation of key inhibitory features and synthesis of a rationally stripped-down nodularin macrocycle | Journal of the Chemical Society, Perkin Transactions 1 | 1997 |